HUBB vs TGTX · P/E 28, rev $5.84B vs P/E 18, rev $240.3M
Hubbell Inc (HUBB) versus TG Therapeutics Inc (TGTX) — a side-by-side from cached financials, not a winner call.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported HUBB revenue for 2025-12-31 was $5.84B. Net income was $887.1M. Revenue was up 3.8% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Latest reported TGTX revenue for 2026-06-30 was $240.3M. Net income was $7.8M. Revenue was up 17.3% from 2026-03-31 to 2026-06-30. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
HUBB currently screens at market cap $22.14B and trailing P/E 28.0. TGTX currently screens at market cap $7.88B and trailing P/E 18.0.
Not investment advice. Open the HUBB and TGTX stock pages for the full models.
Not investment advice.